Human Chorionic Gonadotropin (hCG) Dosing for Fertility and Hypogonadism
For fertility treatments, the standard dose of hCG is 5,000-10,000 IU administered intramuscularly as a single dose, while for hypogonadism in males, the typical dose is 500-2,500 IU administered 2-3 times weekly.
Dosing for Fertility Treatments
Ovulation Induction in Women
- Standard dose: 5,000-10,000 IU as a single intramuscular injection 1
- Typically administered one day following the last dose of menotropins/FSH in controlled ovarian stimulation protocols 2
- The 5,000 IU dose is generally sufficient to trigger ovulation, while 10,000 IU may be preferred for luteal phase support 3
- Administration timing: When at least three follicles >17mm are present with appropriately rising estradiol levels 2
Route of Administration
- Traditionally given intramuscularly, but subcutaneous administration is also effective:
Dosing for Male Hypogonadism
Hypogonadotropic Hypogonadism
- FDA-approved regimens: 1
- 500-1,000 IU three times weekly for three weeks, followed by the same dose twice weekly for three weeks
- 4,000 IU three times weekly for six to nine months, then reduced to 2,000 IU three times weekly for an additional three months
Clinical Practice Guidelines
- The AUA guideline recommends hCG injections of 500-2,500 IU administered 2-3 times weekly 2
- This regimen is particularly important for men wishing to maintain fertility, as exogenous testosterone therapy suppresses spermatogenesis 2
- Response to treatment correlates with testicular size prior to treatment 2
Treatment Outcomes
- Normalizes serum testosterone levels in most patients 5, 6
- Increases testicular volume in approximately 92% of patients 5
- Can initiate and maintain spermatogenesis in some patients even without FSH supplementation 5
- Comparable effectiveness to clomiphene citrate for testosterone restoration, with a 223% increase in testosterone levels after 3 months 6
Special Considerations
Cryptorchidism in Children
- Dosing options: 1
- 4,000 IU three times weekly for three weeks
- 5,000 IU every second day for four injections
- 15 injections of 500-1,000 IU over six weeks
- 500 IU three times weekly for four to six weeks
Prader-Willi Syndrome
- A therapeutic trial of hCG is indicated for treatment of undescended testes before surgery 2
- Benefits include increased scrotal size and partial normalization of phallus length 2
Important Clinical Pearls
Fertility preservation: hCG is preferred over exogenous testosterone for men with hypogonadism who wish to preserve fertility 2
Monitoring: Regular monitoring of testosterone levels is recommended to ensure adequate response
Combination therapy: For patients with inadequate response to hCG alone, addition of FSH (human menopausal gonadotropin or recombinant FSH) may be necessary 5
Prior testosterone use: Previous testosterone therapy does not appear to negatively impact response to hCG treatment 5
Storage: Use completely within 60 days after reconstitution and refrigerate after reconstitution 1